The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
CD133: a stem cell biomarker and beyond
Open accessAbstract
Cancer stem cells (CSCs) or tumor initiating cells (TICs) contribute to tumorigenesis, metastasis, recurrence and chemoresistance. CD133, a pentaspan membrane glycoprotein, has been used as a stem cell biomarker for isolation of stem-like cells from a variety of normal and pathological tissues as well as cell lines since its discovery in 1999. Recent studies are focusing on the functionality of CD133. In this review, we summarize new insights into CD133 regulation and the involvement of CD133 in cell self-renewal, tumorigenesis, metastasis, resistance, metabolism, differentiation, autophagy, apoptosis, and regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, D., Zhu, H., Zhu, Y., Liu, Y., Shen, H., Yin, R.-G., Zhang, Z., & Su, Z. (2012) · Acta Histochemica · doi:10.1016/j.acthis.2012.09.007 · Cited by 40
RetractedAC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5002 · Cited by 1,822
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., Bray, R. A., Waller, E. K., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5013 · Cited by 984
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656
Weigmann, A., Corbeil, D., Hellwig, A., & Huttner, W. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12425 · Cited by 608
ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant Melanoma
Frank, N. Y., Margaryan, A., Huang, Y., Schatton, T., Waaga-Gasser, A. M., Gasser, M., Sayegh, M. H., Sadee, W., & Frank, M. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3327 · Cited by 574
Röper, K., Corbeil, D., & Huttner, W. B. (2000) · Nature Cell Biology · doi:10.1038/35023524 · Cited by 555
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
Baba, T., Convery, P. A., Matsumura, N., Whitaker, R. S., Kondoh, E., Perry, T., Huang, Z., Bentley, R. C., Mori, S., Fujii, S., et al. (2009) · Oncogene · doi:10.1038/onc.2008.374 · Cited by 419
Ma, S., Tang, K. H., Chan, Y. P., Lee, T. K., Kwan, P. S., Castilho, A., Ng, I., Man, K., Wong, N., To, K.-F., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.010 · Cited by 383
The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
Kemper, K., Sprick, M. R., de Bree, M., Scopelliti, A., Vermeulen, L., Hoek, M., Zeilstra, J., Pals, S. T., Mehmet, H., Stassi, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1820 · Cited by 372
Shmelkov, S. V., St.Clair, R., Lyden, D., & Rafii, S. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.08.010 · Cited by 348
Prominin: A Story of Cholesterol, Plasma Membrane Protrusions and Human Pathology
Corbeil, D., Röper, K., Fargeas, C. A., Joester, A., & Huttner, W. B. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.020202.x · Cited by 316
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Y., & Wu, P. Y. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0338 · Cited by 293
Dubreuil, V., Marzesco, A.-M., Corbeil, D., Huttner, W. B., & Wilsch-Bräuninger, M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608137 · Cited by 290
Zhang, Q., Shi, S., Yen, Y., Brown, J., Ta, J. Q., & Le, A. D. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.08.010 · Cited by 278
Wei, Y., Jiang, Y., Zou, F., Liu, Y., Wang, S., Xu, N., Xu, W., Cui, C., Xing, Y., Liu, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217002110 · Cited by 274
Lottaz, C., Beier, D., Meyer, K., Kumar, P., Hermann, A., Schwarz, J., Junker, M., Oefner, P. J., Bogdahn, U., Wischhusen, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1707 · Cited by 272
MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma
Garzia, L., Andolfo, I., Cusanelli, E., Marino, N., Petrosino, G., De Martino, D., Esposito, V., Galeone, A., Navas, L., Esposito, S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004998 · Cited by 255
Tang, K. H., Ma, S., Lee, T. K., Chan, Y. P., Kwan, P. S., Tong, C. M., Ng, I. O., Man, K., To, K.-F., Lai, P. B., et al. (2012) · Hepatology · doi:10.1002/hep.24739 · Cited by 251
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Griguer, C. E., Oliva, C. R., Gobin, E., Marcorelles, P., Benos, D. J., Lancaster, J. R., & Gillespie, G. Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003655 · Cited by 247
am Esch, J. S., Knoefel, W. T., Klein, M., Ghodsizad, A., Fuerst, G., Poll, L. W., Piechaczek, C., Burchardt, E. R., Feifel, N., Stoldt, V., et al. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0283 · Cited by 244
Epigenetic Regulation of Cancer Stem Cell Marker Cd133 by Transforming Growth Factor-β
You, H., Ding, W., & Rountree, B. C. (2010) · Hepatology · doi:10.1002/hep.23544 · Cited by 221
CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells
Haraguchi, N., Ohkuma, M., Sakashita, H., Matsuzaki, S., Tanaka, F., Mimori, K., Kamohara, Y., Inoue, H., & Mori, M. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0074-0 · Cited by 211
Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., & Zhu, B. (2012) · STEM CELLS · doi:10.1002/stem.1194 · Cited by 202
CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
Piao, L. S., Hur, W., Kim, T.-K., Hong, S. W., Kim, S. W., Choi, J. E., Sung, P. S., Song, M. J., Lee, B.-C., Hwang, D., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.10.012 · Cited by 197
Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?
Neuzil, J., Stantic, M., Zobalova, R., Chladova, J., Wang, X., Prochazka, L., Dong, L., Andera, L., & Ralph, S. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.159 · Cited by 189
Storci, G., Sansone, P., Mari, S., D'Uva, G., Tavolari, S., Guarnieri, T., Taffurelli, M., Ceccarelli, C., Santini, D., Chieco, P., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22264 · Cited by 189
Wakamatsu, Y., Sakamoto, N., Oo, H. Z., Naito, Y., Uraoka, N., Anami, K., Sentani, K., Oue, N., & Yasui, W. (2012) · Pathology International · doi:10.1111/j.1440-1827.2011.02760.x · Cited by 175
Swindall, A. F., Londoño-Joshi, A. I., Schultz, M. J., Fineberg, N., Buchsbaum, D. J., & Bellis, S. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3424 · Cited by 164
CD133+CXCR4+ colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
Zhang, S.-S., Han, Z.-P., Jing, Y.-Y., Tao, S.-F., Li, T.-J., Wang, H., Wang, Y., Li, R., Yang, Y., Zhao, X., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-85 · Cited by 164
Fang, D. D., Kim, Y. J., Lee, C. N., Aggarwal, S., McKinnon, K. M., Mesmer, D., Norton, J., Birse, C. E., He, T., Ruben, S. M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605610 · Cited by 163
Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
Yi, J. M., Tsai, H.-C., Glöckner, S. C., Lin, S. H., Ohm, J. E., Easwaran, H., James, C. D., Costello, J., Riggins, G. J., Eberhart, C. G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6208 · Cited by 162
Cheung, S., Cheung, P. F., Cheng, C. K. C., Wong, N. C. L., & Fan, S. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.049 · Cited by 142
Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
Suzuki, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1207 · Cited by 141
mTOR Signal and Hypoxia-Inducible Factor-1α Regulate CD133 Expression in Cancer Cells
MATSUMOTO, K. Y., Arao, T., Tanaka, K., Kaneda, H., Kudo, K., Fujita, Y., Tamura, D., Aomatsu, K., Tamura, T., Yamada, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1289 · Cited by 140
miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells
Huang, S., Guo, W., Tang, Y., Ren, D., Zou, X., & Peng, X. (2012) · Oncology Reports · doi:10.3892/or.2012.2015 · Cited by 137
Yan, X. S., Ma, L., Yi, D., Yoon, J.-G., Diercks, A. H., Foltz, G., Price, N. D., Hood, L., & Tian, Q. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018696108 · Cited by 136
Zhang, J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1242 · Cited by 129
The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers
Hou, Y., Zou, Q., Ge, R., Shen, F., & Wang, Y. (2011) · Cell Research · doi:10.1038/cr.2011.139 · Cited by 128
Global Gene Expression Profile of Human Cord Blood–Derived CD133+ Cells
Jaatinen, T., Hemmoranta, H., Hautaniemi, S., Niemi, J., Nicorici, D., Laine, J., Yli-Harja, O., & Partanen, J. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0185 · Cited by 121
Promoter hypomethylation regulates CD133 expression in human gliomas
Tabu, K., Sasai, K., Kimura, T., Wang, L., Aoyanagi, E., Kohsaka, S., Tanino, M. A., Nishihara, H., & Tanaka, S. (2008) · Cell Research · doi:10.1038/cr.2008.270 · Cited by 121
Corbeil, D., Marzesco, A., Wilsch‐Bräuninger, M., & Huttner, W. Β. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.050 · Cited by 120
Liver cancer: the role of stem cells
Alison, M. R., & Lovell, M. J. (2005) · Cell Proliferation · doi:10.1111/j.1365-2184.2005.00354.x · Cited by 119
Kwee, S. A., Hernandez, B. Y., Chan, O. T. M., & Wong, L. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046591 · Cited by 118
Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells
Wang, Y. K., Zhu, Y., Qiu, F., Zhang, T., Chen, Z., Zheng, S., & Huang, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq120 · Cited by 112
Hashimoto, O., Shimizu, K., Semba, S., Chiba, S., Ku, Y., Yokozaki, H., & Hori, Y. (2011) · Pathobiology · doi:10.1159/000325538 · Cited by 108
Elsaba, T. M., Martínez‐Pomares, L., Robins, A., Crook, S., Seth, R., Jackson, D., Reed, A. E. M., Silver, A. R., Tomlinson, I. P. M., & Ilyas, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010714 · Cited by 104
Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
Kemper, K., Versloot, M., Cameron, K., Çolak, S., Melo, F. D. S. E., de Jong, J. H., Bleackley, J., Vermeulen, L., Versteeg, R., Köster, J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3066 · Cited by 102
Okudela, K., Woo, T., Mitsui, H., Tajiri, M., Masuda, M., & Ohashi, K. (2012) · Pathology International · doi:10.1111/pin.12019 · Cited by 100
Chen, K., Pan, F., Jiang, H., Chen, J., Li, P. Z., Xie, F., & Liang, H. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9407-7 · Cited by 100
Kohga, K., Tatsumi, T., Takehara, T., Tsunematsu, H., Shimizu, S., Yamamoto, M., Sasakawa, A., Miyagi, T., & Hayashi, N. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.030 · Cited by 100
Ding, W., Mouzaki, M., You, H., Laird, J. C., Mato, J. M., Lu, S. C.-L., & Rountree, B. C. (2008) · Hepatology · doi:10.1002/hep.22743 · Cited by 97
CD44+CD133+population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma
Shi, C., Tian, R., Wang, M., Wang, X., Jiang, J., Zhang, Z., Li, X., He, Z., Gong, W., & Qin, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13664 · Cited by 95
Kusumbe, A. P., Mali, A. M., & Bapat, S. A. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0868 · Cited by 94
Shi, M., Ishikawa, M., Kamei, N., Nakasa, T., Adachi, N., Deie, M., Asahara, T., & Ochi, M. (2009) · Stem Cells · doi:10.1002/stem.4 · Cited by 93
Bissels, U., Wild, S., Tomiuk, S., Hafner, M., Scheel, H., Mihailović, A., Choi, Y., Tuschl, T., & Bosio, A. (2011) · Stem Cells · doi:10.1002/stem.627 · Cited by 93
Stem Cell Marker Prominin-1/AC133 Is Expressed in Duct Cells of the Adult Human Pancreas
Lardon, J., Corbeil, D., Huttner, W. Β., Ling, Z., & Bouwens, L. (2008) · Pancreas · doi:10.1097/mpa.0b013e318149f2dc · Cited by 90
Boivin, D., Labbé, D. P., Fontaine, N., Lamy, S., Beaulieu, É., Gingras, D., & Béliveau, R. (2009) · Biochemistry · doi:10.1021/bi900159d · Cited by 88
Bourseau-Guilmain, E., Griveau, A., Benoît, J., & Garcion, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025515 · Cited by 81
Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells
Angelastro, J. M., & Lamé, M. W. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0383 · Cited by 80
Insight into the complex regulation of CD133 in glioma
Campos, B., & Herold‐Mende, C. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25687 · Cited by 73
Hemmoranta, H., Satomaa, T., Blomqvist, M., Heiskanen, A., Aitio, O., Saarinen, J., Natunen, J., Partanen, J., Laine, J. T., & Jaatinen, T. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.05.006 · Cited by 70
Expression profiling of CD133+ and CD133— epithelial cells from human prostate
Shepherd, C. J., Rizzo, S., Ledaki, I., Davies, M. C., Brewer, D. S., Attard, G., Bono, J. S. D., & Hudson, D. L. (2008) · The Prostate · doi:10.1002/pros.20765 · Cited by 70
Nikeghbalian, S., Pournasr, B., Aghdami, N., Rasekhi, A., Geramizadeh, B., Asl, S. M. K. H., Ramzi, M., Kakaei, F., Namiri, M., Malekzadeh, R., et al. (2011) · PubMed · Cited by 67
Tumor microenvironment and breast cancer progression: A complex scenario
Artacho-Cordón, A., Artacho‐Cordón, F., Ríos‐Arrabal, S., Calvente, I., & Núñez, M. I. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.1.18869 · Cited by 59
2,3-Sialylation regulates the stability of stem cell marker CD133
Zhou, F., Cui, C., Ge, Y., Chen, H., Li, Q., Yang, Z., Wu, G. C., Sun, S., Chen, K., Gu, J., et al. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq062 · Cited by 59
Lyshchik, A. P., Higashi, T., Hara, T., Nakamoto, Y., Fujimoto, K., Doi, R., Imamura, M., Saga, T., & Togashi, K. (2007) · Cancer Investigation · doi:10.1080/07357900701208931 · Cited by 59
CD133 positive progenitor endothelial cell lines from human cord blood
Paprocka, M., Krawczenko, A., Duś, D., Kantor, A., Carreau, A., Grillon, C., & Kiéda, C. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21092 · Cited by 52
Yang, Z., Zhang, L., Ma, A., Liu, L., Li, J., Gu, J., & Liu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028405 · Cited by 52
Vadysirisack, D. D., & Ellisen, L. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_4 · Cited by 50
CD133+gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity
Shi, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i24.2965 · Cited by 48
Shi, L., Wan, Y., Sun, G., Gu, X., Qian, C., Yan, W., Zhang, S., Pan, T., Wang, Z., & You, Y. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8188-8 · Cited by 46
CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells
Lehnus, K. S., Donovan, L., Huang, X., Zhao, N., Warr, T. J., Pilkington, G. J., & An, Q. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1787 · Cited by 44
CD133 Affects the Invasive Ability of HCT116 Cells by Regulating TIMP-2
Zhang, M., Liu, Y., Feng, H., Bian, X., Zhao, W., Yang, Z., Gu, B., Li, Z., & Liu, Y. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.10.015 · Cited by 39
Self-citationSafety and efficacy of bone marrow-derived autologous CD133 stem cell therapy
Das, H. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e265 · Cited by 36
Ex-vivo expanded human blood-derived CD133+ cells promote repair of injured spinal cord
Kamei, N., Kwon, S., Alev, C., Nakanishi, K., Yamada, K., Masuda, H., Ishikawa, M., Kawamoto, A., Ochi, M., & Asahara, T. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.02.013 · Cited by 33
Corbeil, D., Marzesco, A., Fargeas, C. A., & Huttner, W. Β. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-8622-8_14 · Cited by 26
Characterization of the conversion between CD133+and CD133-cells in colon cancer SW620 cell line
Feng, J., Miao, Z., Jiang, Y., Chen, Y. G., Li, J.-X., Tong, L., Zhang, J., Huang, Y., & Ding, J. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.22000 · Cited by 23
Overactivation of Ras signaling pathway in CD133+ MPNST cells
Borrego-Diaz, E., Terai, K., Lialyte, K., Wise, A. L., Esfandyari, T., Behbod, F., Mautner, V. F., Spyra, M., Taylor, S. A., Parada, L. F., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0852-1 · Cited by 21
The Potential Role of CD133 in Immune Surveillance and Apoptosis: A Mitochondrial Connection?
Zobalová, R., Rohlenová, K., Stantic, M., Stapelberg, M., Dong, L., Ralph, S. J., Akporiaye, E. T., & Neužil, J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3785 · Cited by 11
Hexokinase II in CD133+ and CD133- Hepatoma BEL-7402 Cells
Gong, L., Zhuqingqing, C., Yu, X., Wei, Y., Peng, J., & Leng, X.-S. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9455-y · Cited by 5
Cited by
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Stem cell-based therapy for human diseases
Hoang, D. M., Pham, P. T., Bach, T. Q., Ngo, A. T. L., Nguyen, Q. T., Phan, T. T. K., Nguyen, G. H., Le, P. T. T., Hoang, V. T., Forsyth, N. R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01134-4 · Cited by 1,074
Cancer stem cells—Origins and biomarkers: Perspectives for targeted personalized therapies
Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01280 · Cited by 1,007
“colon (compare Tables 1–5) and has also been described as a marker that characterizes cells with high tumorigenicity and a high ability to form spheroids (184, 469).”
BackgroundCancer stem cells in colorectal cancer: a review
Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T., & Itinteang, T. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204739 · Cited by 304
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
Metadata
- Authors
- Li, Z.
- Venue
- Experimental Hematology & Oncology
- Published
- 2013-07-01
- Volume
- 2
- Issue
- 1
- Pages
- 17-17
- ISSN
- 2162-3619 (ISSN-L)
- OpenAlex
- W2126968178
- Cited by
- 331
- References
- 84
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.